Compare PLXS & NAKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLXS | NAKA |
|---|---|---|
| Founded | 1979 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 347.4M |
| IPO Year | 1986 | 2024 |
| Metric | PLXS | NAKA |
|---|---|---|
| Price | $150.44 | $0.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $157.50 | $4.50 |
| AVG Volume (30 Days) | 164.5K | ★ 14.1M |
| Earning Date | 01-21-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 56.11 | N/A |
| EPS | ★ 6.26 | N/A |
| Revenue | ★ $4,032,966,000.00 | $1,980,278.00 |
| Revenue This Year | $10.99 | N/A |
| Revenue Next Year | $7.02 | $2,774.04 |
| P/E Ratio | $24.02 | ★ N/A |
| Revenue Growth | ★ 1.82 | N/A |
| 52 Week Low | $103.43 | $0.43 |
| 52 Week High | $172.89 | $34.77 |
| Indicator | PLXS | NAKA |
|---|---|---|
| Relative Strength Index (RSI) | 60.30 | 35.16 |
| Support Level | $141.26 | $0.47 |
| Resistance Level | $151.86 | $0.56 |
| Average True Range (ATR) | 5.09 | 0.05 |
| MACD | 1.22 | 0.05 |
| Stochastic Oscillator | 88.05 | 46.03 |
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.